Useful mavacamten resources

Mavacamten Long-term extension data (MAVA-LTE) & Real World Evidence: Insights and Implications — Speaker: Dr. Jason Dungu

From early adoption to embedded practice: Mavacamten at 3.5Y — Speaker: Prof Andrew Crean

Identifying the right Mavacamten patient and why — Speaker: Dr. Alison Muir

Professor Andrew Crean and Ivo Andrade from Manchester Foundation Trust describing step-by-step instructions on what to expect when performing a Goal-Directed Valsalva Manoeuvre for patients with Obstructive Hypertrophic Cardiomyopathy (oHCM).

Professor Andrew Crean and Ivo Andrade from Manchester Foundation describing a straightforward and reproducible way of demonstrating a gradient in patients with obstructive hypertrophic cardiomyopathy (oHCM)

How to design hub-and-spoke models for specialist cardiology services - An example from Swindon and Oxford University Hospitals

The role of hub-and-spoke models in the management of obstructive hypertrophic cardiomyopathy (oHCM) patients.

An expert perspective on the identification and management of obstructive hypertrophic cardiomyopathy (oHCM) patients.

Hear from panellists as they share their thoughts and standout moments from ICC Mobilise 2025 in this highlight video.

Listen to cardiologists Dr Sanjay Bhandari and Dr Harshil Dhutia provide expert insights into the imaging and symptomatology of hypertrophic cardiomyopathy.

This video highlights key molecular hallmarks of obstructive HCM and how mavacamten works.

Educational material to support appropriate mavacamten dosing for patients.

Educational material that can be given to patients who have been prescribed mavacamten. This booklet offers information to patients about obstructive HCM, how mavacamten works, monitoring requirements, how to take mavacamten, potential side effects, and drug interactions.

Hear from nurses and midwives as they discuss ICC service opportunities and challenges across the four nations of the UK in this video from ICC Mobilise 2025.

Hear from panellists as they share their thoughts and standout moments from ICC Connect 2025 in this highlight video

Footage from the BMS Sponsored Symposium at the British Inherited Cardiovascular Conditions (BICCS) Annual Conference in December 2025. Dr. Rachel Bastiaenen shares her perspectives on the impact of Mavacamten on patients and ICC Services.

Footage from the BMS Sponsored Symposium at the British Inherited Cardiovascular Conditions (BICCS) Annual Conference in December 2025. Hear from Dr Shveta Monga as she describes setting up a Mavacamten Service in Swindon.